Spire Wealth Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$483K Buy
2,475
+512
+26% +$106K 0.01% 558
2026
Q1
$441K Buy
1,963
+590
+43% +$147K 0.02% 575
2025
Q4
$331K Sell
1,373
-5,666
-80% -$1.45M 0.01% 650
2025
Q3
$1.93M Buy
7,039
+995
+16% +$272K 0.07% 241
2025
Q2
$1.54M Buy
6,044
+3,458
+134% +$825K 0.06% 282
2025
Q1
$579K Sell
2,586
-8,214
-76% -$1.92M 0.02% 530
2024
Q4
$2.47M Buy
10,800
+1,100
+11% +$265K 0.08% 219
2024
Q3
$2.37M Sell
9,700
-14,398
-60% -$3.22M 0.08% 203
2024
Q2
$4.61M Sell
24,098
-2,630
-10% -$534K 0.16% 130
2024
Q1
$5.29M Sell
26,728
-7,733
-22% -$1.42M 0.1% 153
2023
Q4
$5.95M Buy
34,461
+34,348
+30,396% +$5.28M 0.2% 107
2023
Q3
$16.7K Sell
113
-11,607
-99% -$2.1M ﹤0.01% 1568
2023
Q2
$2.56M Sell
11,720
-891
-7% -$199K 0.09% 199
2023
Q1
$2.76M Buy
12,611
+12,407
+6,082% +$2.69M 0.11% 183
2022
Q4
$43K Buy
204
+6
+3% +$1.32K ﹤0.01% 1040
2022
Q3
$43K Buy
198
+5
+3% +$1.14K ﹤0.01% 1005
2022
Q2
$40K Sell
193
-10
-5% -$2.13K ﹤0.01% 1382
2022
Q1
$49K Buy
203
+5
+3% +$1.21K ﹤0.01% 1457
2021
Q4
$52K Sell
198
-12
-6% -$3.11K ﹤0.01% 1711
2021
Q3
$55K Sell
210
-3
-1% -$820 ﹤0.01% 1436
2021
Q2
$53K Hold
213
﹤0.01% 1455
2021
Q1
$41K Buy
+213
New +$42.7K ﹤0.01% 1832

Other funds holding RMD

Spire Wealth Management's RMD Position: Q2 2026 in Review

Spire Wealth Management increased its ResMed (RMD) stake by 26% in Q2 2026, buying an estimated $106K and bringing the position to 2,475 shares worth $483K. The position accounts for 0.01% of the portfolio, ranked #558.

Spire Wealth Management first reported a position in RMD in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.95M in Q4 2023. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Spire Wealth Management held 2,475 shares of ResMed worth $483K as of Q2 2026.
  • Spire Wealth Management bought 512 ResMed shares in Q2 2026, an estimated $106K.
  • ResMed made up 0.01% of Spire Wealth Management's portfolio in Q2 2026, its #558 holding.
  • Spire Wealth Management first reported a position in ResMed in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's ResMed position peaked at $5.95M in Q4 2023.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.